Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artemether-lumefantrine versus artesunate-amodiaquine in pregnant women with uncomplicated falciparum malaria
PACTR201310000484185Completed
- Sponsor
- Ukah Chukwuemeka Marcel
- Start
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of artemether, lumefantrine, artesunate and amodiaquine in Malaria (2 arms), sponsored by Ukah Chukwuemeka Marcel. Primary endpoint: Comparative efficacy of artemether-lumefantrine versus artesunate-amodiaquine. Started Jan 2013; status: completed.
02
Drugs
artemetherlumefantrineartesunateamodiaquine
03
Conditions
Malaria
Beyond the preview
Go deeper on PACTR201310000484185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201310000484185.